Recently, the Department of International Cooperation of the State Administration of Traditional Chinese Medicine issued a bid-winning announcement for the "Special Project for International Cooperation in Traditional Chinese Medicine (Base Project)". Jiangyin Tianjiang Pharmaceutical Co., Ltd. successfully won the bid for the "International Cooperation Base for the Development of Traditional Chinese Medicine Formula Granules Industry" project, and is the only Chinese medicine formula granule enterprise that has been approved as a special base project for international cooperation in traditional Chinese medicine.
"It is of great significance to our company to be recognized by the country. It is also a spur and a responsibility." Li Xinggao, Director of Overseas Business Department of Jiangyin Tianjiang Pharmaceutical Co., Ltd. said, winning the bid for this project, Tianjiang Pharmaceutical will build a " The Global TCM Academic Promotion Platform” organizes professional and regular academic activities for overseas TCM practitioners through a combination of online and offline methods, so as to improve the drug use level and experience of overseas practitioners, including TCM physicians and acupuncturists, and enhance Their cognition and trust in China's modern Chinese medicine industry has effectively enhanced the influence of corporate brands overseas, and spread the health and well-being of Chinese medicine to people all over the world more, faster and on a wider scale, thus accumulating more profound Mass Basis. In Li Xinggao's view, these are not only the core of realizing real industrialization, but also lay a solid foundation for Chinese medicine to go out and go up, and pave the way for the real internationalization of Chinese medicine.
As the pioneer and leader of the Chinese medicine formula granule industry, Tianjiang Pharmaceutical is affiliated to China Traditional Chinese Medicine Holdings Co., Ltd. under the Sinopharm Group, and is the first batch of pilot manufacturers of Chinese medicine formula granules approved by the State Drug Administration. Founded more than 30 years ago, Tianjiang Pharmaceutical has always regarded the internationalization of traditional Chinese medicine as one of its core goals. It is the earliest exporter of traditional Chinese medicine formula granules in China, and its products have covered more than 30 countries and regions around the world.
Research on international standards
Tianjiang Pharmaceutical actively participates in the formulation of international standards for traditional Chinese medicine, and is the core maker of the ISO/TC249 standard for formula granules of traditional Chinese medicine. At the same time, the United States Pharmacopoeia standard research was carried out, Among them, the standard of Coptidis Formula Granules has been publicized and solicited opinions on September 1, 2022, becoming the world's first standard of traditional Chinese medicine formula granules included in the HMC Department of the United States Pharmacopoeia.
International Quality Management System Certification
Tianjiang Pharmaceutical has passed the GMP certification of Australia's TGA and the CGMP on-site certification of the US FDA, and its product quality has been widely recognized by European and American countries.
Overseas academic aspects
Tianjiang Pharmaceutical and the North American market dominated by the United States, the European market dominated by Austria and the United Kingdom, the Southeast Asian market dominated by Xinmatai and
Associations of Chinese Medicine Physicians, Schools of Chinese Medicine and practitioners in the Chinese medicine industry in Hong Kong and Macau have established extensive and good cooperative relations and carried out a series of rich international exchange activities.
Tianjiang Pharmaceutical
In addition, Tianjiang Pharmaceutical has also achieved remarkable results in overseas epidemic prevention and fighting. Based on the existing overseas cooperation system, Tianjiang Pharmaceutical has donated and provided epidemic prevention and anti-epidemic products to Chinese, overseas Chinese and local people in nearly 20 countries and regions, with a total of more than one million person-times. Among them, the anti-epidemic products Hayes No. 3 and Hayes No. 5 registered in Kenya have been highly praised by the Kenyan government, experts and people.
Related Products about Chinese Medicine
Ren Shen Wu Bao Cha
Xiao Chai Hu Tang - Minor Bupleurum Decoction (Granules)
Yi Mu Che Xi